➠ 1. Li, J., Liu, L., Cao, H., Yang, M., Sun, X.. Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”. Cost Effectiveness and Resource Allocation (2023)
➠ 2. J Januzzi, X Tan, L Yang, J Brady, M Yang, P Banka, D Lautsch N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction. ESC Heart Fail (2022)
➠ 3. R Mentz, D Lautsch, Z Pulungan, S Kim, R Hilkert, C Teigland, M Yang, L Djatche Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction. Journal of Cardiac Failure (2021)
➠ 4. Fendrick AM, Djatche L, Pulungan Z, Teigland C, Yang M, Lautsch D, Hilkert R, Mentz R. Out-of-pocket payments for part d covered medications by medicare fee-for-service beneficiaries with heart failure with reduced ejection fraction. Am Heart J. (2021)
➠ 5. Wang Z, Chen X, Tan X, Yang L, Kannapur K, Vincent JL, Kessler GN, Ru B, Yang M. Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction. J Health Econ Outcomes Res. 2021
➠ 6. Dunbar SB, Tan X, Lautsch D, Yang M, Ricker B, Maculaitis MC, Nagle T, Clark LT, Hilkert R, Brady JE, Spertus JA. Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis. J Card Fail. (2021)
➠ 7. Butler J, Yang M, Sawhney B, Chakladar S, Yang L, Djatche LM. Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event. Eur J Heart Fail. (2021)
➠ 8. Givertz MM, Yang M, Hess GP, Zhao B, Rai A, Butler J. Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event. ESC Heart Fail. (2021)
➠ 9. Dong X, Zhou Y, Shu X, Bernstam E, Stern R, Aronoff DM, Xu H, Lipworth L. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database. Microbiol Spectr. (2021)
➠ 10. P Goyal, B Bose, R Masteron Creber, U Krishnan, M Yang, J Brady, J Pathak. Performance of Electronic Health Record Diagnosis Codes for Ambulatory Heart Failure Encounters. Journal of Cardiac Failure (2020)
➠ 11. J Butler, L M. Djatche, B Sawhney, S Chakladar, L Yang, J E. Brady, M Yang. Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event. Advances in Therapy (2020)
➠ 12. Dong X, Li J, Soysal E, Bian J, DuVall S, Hanchrow E, Liu H, Lynch K, Matheny M, Natarajan K, Ohno-Machado L, Pakhomov S, Reeves R, Sitapati A, Abhyankar S, Cullen T, Deckard J, Jiang X, Murphy R, Xu H. COVID-19 TestNorm—a tool to normalize COVID-19 testing names to LOINC codes. Journal of American Medical Informatics Association. (2020)
➠ 13. Zuo X, Li J, Zhao B, Zhou Y, Dong X , Duke J, Natarajan K, Hripcsak G, Shah N, Banda J, Reeves MR, Xu H. Normalizing clinical document titles to LOINC document ontology:
an initial study. AMIA 2020 Annual Symposium Proceedings
➠ 14. Butler J, Yang M, Manzi MA, Hess GP, Patel MJ, Rhodes T, Givertz MM. Clinical Course of Patients with Worsening Heart Failure with Reduced Ejection Fraction. J Am Coll Cardiol. (2019)
➠ 15. Miao S, Dong X (co-first author), Zhang X, Jing S, Zhang X, Xu T, Wang L, Du X, Xu H, Liu Y. Detecting pioglitazone use and risk of cardiovascular events using electronic health record data in a large cohort of Chinese patients with type 2 diabetes. Journal of Diabetes. (2019)
➠ 16. J Marcus, K Lasch, Y Wan, M Yang, C Hsu and D Merante. An Assessment of Clinically Important Differences on the Worst Pain Severity Item of the Modified Brief Pain Inventory in Patients with Diabetic Peripheral Neuropathic Pain. Pain Research and Management. (2018)
➠ 17. Chen H, Shi L, Xue M, Wang N, Dong X, Cai Y, Chen J, Zhu W, Xu H, Meng Q. Geographic variations in in-hospital mortality and use of percutaneous coronary intervention following acute myocardial infarction in China: a nationwide cross-sectional analysis. Journal of the American Heart Association. (2018)
➠ 18. Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick R, Wu X, Yuan Y. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. American Journal of Gastroenterology. (2017)
➠ 19. Liu Y, Qian C, Yang M. Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States. J Manag Care Spec Pharm. (2016)
➠ 20. Yang M, Qian C, Liu Y. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States. Pain Med. (2015)
➠ 21. Dong X, Zhang Y, Xu H. Search datasets in literature: a case study of GWAS. 2017 Joint Summits on Translational Science of AMIA Xu J, Zhang Y, Wu Y, Wang J, Dong X, and Xu H. Citation sentiment analysis in clinical trial papers. AMIA Annual Symposium Proceedings. (2015)
➠ 22. Colombel JF, Rutgeerts PJ, Sandborn WJ, Yang M, Camez A, Pollack PF, Thakkar RB, Robinson AM, Chen N, Mulani PM, Chao J. Adalimumab induces deep remission in patients with Crohn's disease. Clin Gastroenterol Hepatol (2014)
➠ 23. Feagan BG, Sandborn WJ, Lazar A, Thakkar RB, Huang B, Reilly N, Chen N, Yang M, Skup M, Mulani P, Chao J. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis. Gastroenterology (2014)
➠ 24. Tu H, Sun LP, Dong X, Gong YH, Xu Q, Long Q, Flanders WD, Smith RA, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. International Journal of Cancer. (2014)
➠ 25. Sandborn WJ, Colombel JF, Panés J, Castillo M, Robinson AM, Zhou Q, Yang M, Thakkar R. Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials. J Crohns Colitis (2013)
➠ 26. Cao K, Lailler N, Zhang Y, Kumar A, Uppal K, Liu Z, Lee E, Wu H, Medrzycki M, Pan C, Ho P, Cooper P, Dong X, Bock C, Bouhassira E, Fan Y. High-resolution mapping of h1 linker histone variants in embryonic stem cells. PLoS Genetics. (2013)
➠ 27. Tu H, Sun LP, Dong X, Gong YH, Xu Q, Jing JJ, Yuan Y. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scandinavian Journal of Gastroenterology. (2014)
➠ 28. W. J. Sandborn1, J.-F. Colombel, G. D'Haens, G. Van Assche, D. Wolf, M. Kron, A. Lazar, A. M. Robinson, M. Yang, J. D. Chao, R. Thakkar One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2. Alimentary Pharmacology & Therapeutics (2012)
➠ 29. Liu Y, Wu EQ, Bensimon AG, Fan CP, Bao Y, Ganguli A, Yang M, Cifaldi M, Mulani P. Cost Per Responder Associated with Biologic Therapies for Crohn's Disease, Psoriasis, and Rheumatoid Arthritis. Adv Ther (2012)
➠ 30. Louis E, Löfberg R, Reinisch W, Camez A, Yang M, Pollack PF, Chen N, Chao J, Mulani PM. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial. J Crohns Colitis. (2012)
➠ 31. D A. Sussman, N Kubiliun, P M. Mulani, J Chao, C Gillis, M Yang, M Lu, M T. Abreu, Comparison of Medical Costs Among Patients Using Adalimumab and Infliximab: A Retrospective Study (COMPAIRS) Inflamm Bowel Dis (2012)
➠ 32. Yang M, Robinson MA, Pollack FP. When Meta-Analysis Misleads. Am J Gastroenterol (2011)
➠ 33. Binion DG, Louis E, Oldenburg B, Mulani PM, Bensimon AG, Yang M, Chao J. Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn’s disease: A meta-analysis. Can J Gastroenterol. (2011).
➠ 34. Loftus EV, Guerin A, Yu AP, Wu EQ, Yang M, Chao J, Mulani PM. Increased Risks of Developing Anxiety and Depression in Young Patients with Crohn’s Disease. Am J Gastroenterol. (2011)
➠ 35. Wise B, Niu J, Yang M, Lane N, Harvey W, Felson D, Hietpas J, Nevitt MC, Sharma L, Torner J, Lewis C, Zhang Y. Patterns of Compartment Involvement in Tibiofemoral Osteoarthritis in Men and Women and in Caucasians and African Americans. Arthritis Care & Research (2011)
➠ 36. Y Liu, M Yang, J Chao, PM Mulani. Greater refill adherence to adalimumab therapy for patients using specialty versus retail pharmacies. Advances in therapy (2010)
➠ 37. T Neog, MC Nevitt, M Yang, JR Curtis, J Torner, DT Felson. Consistency of knee pain: Correlates and association with function. Osteoarthritis and Cartilage (2010)
➠ 38. F Eckstein, M Yang, A Guermazi, FW Roemer, M Hudelmaier, K Picha, F Baribaud, W Wirth, DT Felso. Reference values and Z-scores for subregional femorotibial cartilage thickness – results from a large population-based sample (Framingham) and comparison with the non-exposed Osteoarthritis Initiative reference cohort. Osteoarthritis Cartilage (2010)
➠ 39. A Guermazi, D Hayashi, FW Roemer, J Niu, M Yang, JA Lynch, JC Torner, CE Lewis, B Sack, DT Felson, MC Nevitt. Cyst-like lesions of the knee joint and their relation to incident knee pain and development of radiographic osteoarthritis: The MOST study. Osteoarthritis Cartilage (2010)
➠ 40. WF Harvey, M Yang, TD Cooke, NA Segal, N Lane, CE Lewis, DT Felson, Association of Leg-Length Inequality With Knee Osteoarthritis: A Cohort Study. Annals of Internal Medicine (2010)
➠ 41. M Englund, A Guermazi, FW Roemer, M Yang, Y Zhang, MC Nevitt, JA Lynch, CE Lewis, J Torner, DT Felson. Meniscal pathology on MRI increases the risk for both incident and enlarging subchondral bone marrow lesions of the knee: the MOST Study. Annals of the rheumatic diseases (2010)
➠ 42. NA Segal, NA Glass, DT Felson, M Hurley, M Yang, M Nevitt, CE Lewis, JC Torner. The Effect of Quadriceps Strength and Proprioception on Risk for Knee Osteoarthritis. Medicine and science in sports and exercise (2010)
➠ 43. NA Segal, NA Glass, J Torner, M Yang, DT Felson, L Sharma, M Nevitt, CE Lewis. Quadriceps weakness predicts risk for knee joint space narrowing in women in the MOST cohort Osteoarthritis and Cartilage (2010)
➠ 44. EY Kissin, J Nishio, M Yang, M Backhaus, PV Balint, GA Bruyn, J Craig-Muller, MA D'Agostino, A Feoktistov, J Goyal, A Iagnocco, RW Ike, I Moller, E Naredo, C Pineda, WA Schmidt, N Swen, D Tabechian, RJ Wakefield, AF Wells, GS Kaeley. Self-directed learning of basic musculoskeletal ultrasound among rheumatologists in the United States. Arthritis care & research (2010)
➠ 45. S Reichenbach, M Yang, F Eckstein, J Niu, DJ Hunter, CE McLennan, A Guermazi, F Roemer, M Hudelmaier, P Aliabadi, D.T. Felson. Does cartilage volume or thickness distinguish knees with and without mild radiographic osteoarthritis? The Framingham Study. Annals of Rheumatic Disease (2009)
➠ 46. DT Felson, KDGross, MV Hurley, M Yang, J Niu, NE Lane, JC Torner, CE Lewis, MC Nevitt. The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis. Arthritis Care & Research (2009)
➠ 47. FW Roemer, A Guermazi, Y Zhang, M Yang, JA Lynch, H Toepfer, DJ Hunter, M Strauswald, MD Crema, MD Marra, K Bohndorf. Hoffa’s Fat Pad: Evaluation on Unenhanced MR Images as a Measure of Patellofemoral Synovitis in Osteoarthritis. American Journal of Roentgenology (2009)
➠ 48. M Englund, A Guermazi, FW Roemer, P Aliabadi, M Yang, CE Lewis, J Torner, M Nevitt,, B Sack, DT Felson. Meniscal Tear in Knees Without Surgery and the Development of Radiographic Osteoarthritis Among Middle-Aged and Elderly Persons: The Multicenter Osteoarthritis Study. Arthritis and rheumatism (2009)
➠ 49. B Wise, S Demissie, LA Cupples, DT Felson, M Yang, AM Shearman, P Aliabadi, DJ Hunter. The relationship of estrogen receptor-alpha and -beta genes with osteoarthritis of the hand. The Journal of Rheumatology (2009)
➠ 50. DT Felson, MC Nevitt, M Yang, M Clancy, J Niu, JC Torner, CE Lewis, P Aliabadi, B Sack, C McCulloch, Y Zhang. A New Approach Yields High Rates of Radiographic Progression in Knee Osteoarthritis. The Journal of Rheumatology (2008)
➠ 51. NA Segal, W Harvey, DT Felson, M Yang, JC Torner, JR Curtis, MC Nevitt. Leg Length Inequality is Not Associated with Greater Trochanteric Pain Syndrome. Arthritis Research & Therapy (2008)
➠ 52. NA Segal, JC Torner, M Yang, JR Curtis, DT Felson, MC Nevitt. Muscle Mass Is More Strongly Related to Hip Bone Mineral Density Than Is Quadriceps Strength Or Activity Level In Adults Over Age 50. Journal of Clinical Densitometry (2008)